Exploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom

scientific article published on 18 February 2019

Exploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S2213-8587(19)30060-9
P698PubMed publication ID30792155

P50authorLourdes IbáñezQ90844952
P2093author name stringFrancis de Zegher
P2860cites workAssociation of a woman's own birth weight with subsequent risk for gestational diabetesQ30309362
Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotypeQ40094463
Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter StudyQ42868207
Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughouQ44785361
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized studyQ44922410
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary SyndromeQ50202586
Polycystic ovary syndrome and risk factors for gestational diabetes.Q55437223
Central Obesity, Faster Maturation, and 'PCOS' in GirlsQ57297775
A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational DiabetesQ57300406
On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysisQ87366711
Pre-Conception Characteristics Predict Obstetrical and Neonatal Outcomes in Women With Polycystic Ovary SyndromeQ90779766
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trialQ91812986
Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitusQ93337273
P433issue4
P921main subjectpolycystic ovaryQ5547896
metforminQ19484
polycystic ovary syndromeQ500816
pregnant personQ104720811
P304page(s)242-243
P577publication date2019-02-18
P1433published inThe Lancet: Diabetes & EndocrinologyQ27725107
P1476titleExploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom
P478volume7

Search more.